Prohibited Mergers and Acquisitions – Secs. 20-22

Competition Review of Corporate Combinations

A merger, consolidation, or acquisition is a corporate transaction under the Revised Corporation Code, but it is also a market transaction when it changes control, competitive incentives, or the structure of a relevant market. Corporate approval asks whether the constituent corporations validly acted through their boards, stockholders, and the Securities and Exchange Commission. Competition review asks whether the transaction will substantially prevent, restrict, or lessen competition.

Under Section 16 of the Philippine Competition Act, the Philippine Competition Commission may review mergers and acquisitions based on factors it considers relevant to competition. The review is substantive, not merely documentary. A transaction may be validly approved as a corporate act but still be prohibited, modified, or conditioned if its competitive effects violate the Philippine Competition Act.

The review covers transactions by their economic substance. A statutory merger, statutory consolidation, share acquisition, asset acquisition, acquisition of control, or competitively significant joint venture may be examined when it combines businesses, removes an independent competitor, transfers market power, or gives one enterprise decisive influence over another.

• Merger. One or more corporations are absorbed into a surviving corporation, which succeeds to the assets, rights, obligations, and liabilities of the absorbed corporations.
• Consolidation. Two or more corporations unite to form a new corporation, and the constituent corporations cease to exist as separate juridical entities.
• Acquisition. One person or enterprise obtains shares, assets, voting rights, contractual rights, or other means of control or decisive influence over another enterprise or business activity.
• Competition consequence. The decisive question is whether the transaction changes market incentives or market structure in a way that harms the competitive process.

Relationship with Corporation Law

The Revised Corporation Code supplies the internal and external corporate mechanics of merger and consolidation, including the plan, approvals, filing, and legal effects. The Philippine Competition Act supplies a separate public-law limitation: private restructuring may not be used to create, strengthen, or entrench market power in a manner that substantially harms competition.

Approval by the Securities and Exchange Commission does not amount to competition clearance. The Securities and Exchange Commission determines compliance with corporation-law requirements. The Philippine Competition Commission determines whether the transaction is competitively permissible. The two inquiries may concern the same transaction, but they protect different legal interests.

Competition review is also distinct from the mandatory notification regime. Notification thresholds determine when parties must seek prior review before consummation. Section 20 liability concerns the substantive effect of the merger or acquisition. A transaction may be notifiable without being prohibited, and a transaction outside notification thresholds may still raise competition concerns if it substantially lessens competition.

Section 20 Prohibition

Section 20 prohibits merger or acquisition agreements that substantially prevent, restrict, or lessen competition in the relevant market or in a market for goods or services. The prohibition focuses on harm to competition itself, not merely harm to an individual competitor, supplier, customer, or contracting party.

A substantial lessening of competition exists when the transaction is likely to give the merged entity the ability or incentive to raise prices, reduce output, degrade quality, slow innovation, limit customer choice, foreclose rivals, coordinate with competitors, or otherwise weaken competitive constraints that would have existed without the transaction.

The inquiry is prospective and comparative. The transaction is assessed against the market conditions likely to exist without it. The analysis considers what competition would look like if the parties remained independent, if one party exited, if another buyer acquired the assets, or if alternative transactions were realistically available.

• Substantiality. The competitive harm must be material in probability, duration, and magnitude; a remote, trivial, or speculative effect is insufficient.
• Relevant market. The market is defined by product substitutes, geographic reach, customer switching, supply substitution, and competitive conditions.
• Market power. Market shares and concentration are important starting points, but they are not conclusive without evidence of entry barriers, rivalry, and customer discipline.
• Merger-specific effect. The harm must arise from the transaction, not from general market decline, ordinary business risk, or preexisting lawful superiority.
• Competition process. The law protects rivalry, contestability, and consumer welfare, not the continued existence of every market participant.

Markets and Competitive Effects

Relevant market definition identifies the area of rivalry affected by the transaction. The product market includes goods or services that customers regard as reasonable substitutes. The geographic market includes the area where customers can practicably turn for alternatives and where suppliers face similar competitive conditions.

Market definition is a tool, not a ritual. The central question remains whether enough competitive pressure will remain after the transaction to discipline the merged entity. A narrow market may reveal market power that a broad label would conceal. A broad market may show that customers can readily switch away from the merged entity.

Theories of Harm

Horizontal mergers are the most direct concern because they combine firms operating at the same level of trade. A horizontal merger may eliminate head-to-head rivalry, remove a maverick competitor, increase concentration, or make coordinated conduct easier by reducing the number of independent competitors.

Unilateral effects occur when the merged entity can profitably worsen price, output, quality, innovation, or service on its own because customers who would have switched between the merging firms are now captured within one enterprise. These effects are strongest when the merging firms are close substitutes and remaining alternatives are weak.

Coordinated effects occur when the transaction makes it easier for firms in the market to reach, monitor, or sustain parallel conduct. A market with few players, transparent prices, stable demand, similar cost structures, and high entry barriers is more vulnerable to coordination after a merger.

Vertical mergers combine firms at different levels of the supply chain, such as an input supplier and a downstream distributor. A vertical transaction may be harmful when it gives the merged entity the ability and incentive to foreclose rivals, raise rivals' costs, deny access to customers, misuse competitively sensitive information, or force exclusivity that weakens rival competition.

Conglomerate or portfolio transactions may be reviewed when the parties sell complementary or related products. Harm may arise from tying, bundling, leveraging a strong position in one market into another, or using combined data, brands, or distribution systems to exclude rivals without offsetting competitive benefits.

Buyer-side effects are also relevant. A transaction may substantially lessen competition where it creates monopsony or buyer power that suppresses supplier prices below competitive levels, reduces output, weakens upstream investment, or harms workers, farmers, creators, or other input providers in a relevant market.

Section 21 Exemptions

Section 21 allows a merger or acquisition that would otherwise fall under Section 20 to be exempted when the parties establish a legally sufficient justification. The exemptions recognize that some transactions producing concentration may nevertheless preserve assets, generate efficiencies, or produce gains that outweigh competitive harm.

Efficiency Justification

The efficiency justification applies when the concentration has brought about, or is likely to bring about, gains in efficiencies that are greater than the effects of any limitation on competition resulting or likely to result from the transaction. The claimed efficiencies must be real competitive gains, not merely private savings transferred from customers, workers, or suppliers to the merged entity.

• Verifiable. Efficiencies must be supported by concrete facts, business records, operating plans, cost data, or other reliable evidence.
• Merger-specific. Efficiencies must be unlikely to be achieved through less restrictive alternatives, such as internal expansion, licensing, supply agreements, or a less anticompetitive buyer.
• Timely. Efficiencies must arise within a period that can realistically offset the likely competitive harm.
• Competition-enhancing. Efficiencies must improve productive capacity, distribution, innovation, quality, resilience, or cost structure in a way relevant to the market.
• Consumer-relevant. Efficiencies carry more weight when they are likely to benefit customers through lower prices, better products, improved service, wider availability, or stronger innovation.

Ordinary claims of synergy are insufficient. The parties must show why the particular merger or acquisition is needed to produce the claimed gains and why those gains outweigh the competitive restraints created by the transaction.

Failing Entity Justification

The failing entity justification applies when a party to the merger or acquisition faces actual or imminent financial failure and the transaction represents the least anticompetitive arrangement among known alternative uses for the failing entity's assets. This justification prevents a rigid competition rule from causing assets to leave the market when a less harmful acquisition can preserve productive use.

• Actual or imminent failure. Financial distress must be serious enough that the entity is unable, or will soon be unable, to meet obligations or remain a viable competitive force.
• Market exit. The assets must be likely to exit the market unless acquired or reorganized through the proposed transaction or another realistic alternative.
• No less anticompetitive alternative. The parties must show that reasonable alternatives, including acquisition by a less problematic buyer, restructuring, or continued operation, are unavailable or inferior from a competition standpoint.
• Asset preservation. The focus is not rescue for its own sake, but whether the transaction preserves productive assets with less harm than the realistic counterfactual.

The failing entity justification is narrow because financial difficulty can be overstated to justify concentration. A weak competitor is not necessarily a failing entity. The relevant question is whether the firm or assets would exit the market and whether the proposed buyer is the least anticompetitive realistic option.

Section 22 Burden of Proof

Section 22 places the burden of proving an exemption on the parties invoking it. Once a transaction is shown to raise substantial competition concerns, the parties must establish the facts supporting efficiencies, failing entity status, or other exemption grounds recognized by law.

The burden is practical as well as legal. The parties control most of the information on transaction rationale, financial condition, projected savings, integration plans, alternative buyers, and market strategy. Unsupported assertions, optimistic projections, or board-level descriptions do not carry the same weight as contemporaneous records and market evidence.

The burden of proof also shapes remedies. If competitive harm is established but the parties prove that targeted commitments can preserve efficiencies while removing the harm, the transaction may be addressed through conditions. If the harm remains and no exemption is proven, the transaction may be prohibited or subjected to remedies proportionate to the competition concern.

Consequences of a Prohibited Merger or Acquisition

A transaction prohibited under Section 20 cannot be justified by the parties' private business purpose, corporate approval, or contractual consent. Competition law treats the transaction as a public concern because market structure affects customers, suppliers, workers, future entrants, and the economy beyond the parties to the agreement.

The Commission may require remedies directed at the competitive harm. Structural remedies address the shape of the market, such as divestiture of a business, assets, rights, or interests. Behavioral remedies regulate conduct, such as access obligations, non-discrimination commitments, firewall requirements, limits on exclusivity, or reporting obligations. Structural relief is generally stronger where the harm arises from ownership and control; behavioral relief is more fitting where conduct can be monitored effectively.

Remedies must be capable of preserving competition, not merely punishing the parties. A remedy that leaves the merged entity with the same ability and incentive to harm competition is inadequate. A remedy that destroys the efficiencies supporting an exemption may also fail to address the transaction coherently.

Integrated Rule

The operative rule is that a merger, consolidation, or acquisition is not assessed only by its corporate form. Under Section 16, the Commission may review the transaction for competitive effects. Under Section 20, the transaction is prohibited if it substantially prevents, restricts, or lessens competition in a relevant market. Under Section 21, the parties may avoid prohibition only by proving legally cognizable efficiencies or a failing entity justification. Under Section 22, the burden of proving the exemption rests on the parties seeking the benefit of the exemption.

The controlling inquiry is whether the transaction leaves the market with enough independent rivalry to protect price, output, quality, innovation, and choice. A corporate combination that merely changes ownership without harming competitive constraints is not prohibited. A corporate combination that removes meaningful rivalry, entrenches market power, forecloses rivals, or enables coordination is prohibited unless the parties prove an exemption sufficient to outweigh or answer the competitive harm.